Complications leading to device explant in patients with chronic non-cancer pain receiving intrathecal drug delivery
Listen to this summary
This study aims to characterize the complications leading to device explant in patients with chronic non-cancer pain receiving intrathecal drug delivery (IDD). The findings reveal that device-related infections are the primary cause of explants, occurring in 9.3% of patients, while loss of analgesic efficacy was less frequent compared to similar complications seen with spinal cord stimulation. Overall, the explant rate was 26.1%, with no significant demographic or comorbidity factors correlating with the need for explantation.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Regional anesthesia and pain medicine
View all →Sep 18, 2026 · Regional anesthesia and pain medicine
Real-time AI-assisted nerve tracking for ultrasound-guided nerve identification: a prospective randomized trial
Sep 15, 2026 · Regional anesthesia and pain medicine
Transcutaneous auricular vagus nerve stimulation to prevent rebound pain after interscalene block for arthroscopic shoulder surgery
Sep 11, 2026 · Regional anesthesia and pain medicine
Caudal versus penile block and urethrocutaneous fistula formation following hypospadias repair in children <2 years: a multicenter randomized clinical trial
Sep 11, 2026 · Regional anesthesia and pain medicine
Ultrasound-guided percutaneous temporary vagus nerve stimulation for refractory post-traumatic chronic pain and post-traumatic stress disorder (PTSD): first reported case and implantation technique
Sep 8, 2026 · Regional anesthesia and pain medicine
Implanted intrathecal drug delivery systems: a narrative review for the perioperative, obstetric, and intensive care anesthesiologist
Sep 8, 2026 · Regional anesthesia and pain medicine
Practical guide to intrathecal drug delivery: short-term and long-term management and complications
More in Anesthesiology
View all →Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Sep 22, 2026 · Lancet (London, England)
Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
